The answer turned out to be a cutting-edge treatment that few Americans know about, according to Roswell Park Comprehensive ...

The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.

Crown BioScience experts explore organoid models and high-content imaging to evaluate T-cell-targeted therapies and ...

Dr. Laura Finn brings new treatment options to Louisiana using genetically altered cells to treat blood cancer patients. Here ...

Researchers have unlocked a powerful new way to fight solid tumors using smart immune cells that stay active longer and hit ...

Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors -- drugs that take the brakes ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns ...

Roswell Park Comprehensive Cancer Center is at the forefront of a new approach to cancer treatment, called CAR T-cell therapy.

Utilizing immune cells called T cells that have been genetically modified in a lab to improve their ability to recognize and eliminate cancer cells, CAR T-cell therapy is a form of cancer ...

As a result, T cells were activated, and tumors significantly shrunk ... However, Sancho’s work highlights a key limitation in the current field of cancer treatment: dendritic cells can often be ...

Novel CAR design selectively targets malignant cells for patients with relapsed/refractory CD5-positive hematological diseasesHOUSTON, April 22, ...